Inari Medical, Inc. (NASDAQ:NARI) Q4 2023 Earnings Call Transcript
Operator: Good day and welcome to Inari Medical's Fourth Quarter and Full Year 2023 Conference Call. At this time, all participants are in a listen-only mode.
Stay updated with breaking news from David Rescott. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good day and welcome to Inari Medical's Fourth Quarter and Full Year 2023 Conference Call. At this time, all participants are in a listen-only mode.
Promising clinical trial results on glucagon-like peptide 1 agonists (GLP-1s) created a seismic shift in the medtech stock market.
In this article, we will take a look at the 15 small-cap stocks with high potential. To skip our analysis of the latest trends, and market activity, you can go directly to see the 5 Small-Cap Stocks with High Potential. Nearly 9,500 stocks trade on major U.S. stock exchanges with nearly half of them having […]
In this article, we will take a look at the 15 small-cap stocks with high potential.
Medtronic stock is taking a hit a day after an FDA review panel found the risks of its renal denervation system outweighed the benefits.